Ectosomes and exosomes: Shedding the confusion between extracellular vesicles

Trends in Cell Biology

Volumn 25, Issue 6, 2015, Pages 364-372

  Cocucci, Emanuele ^a,b   Meldolesi, Jacopo ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cancer diagnosis and therapy; Cell targets; Endocytosis; ESCRT; Extracellular vesicles; Membrane fusions mediated by fusogens; Multivesicular bodies; Vesicle assembly; Vesicle pinching off and release

Indexed keywords

BIOGENESIS; CELL COMMUNICATION; CELL FUSION; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; ECTOSOME; EXOSOME; MULTIVESICULAR BODY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL; EXOCYTOSIS; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; EXOCYTOSIS; EXOSOMES; HUMANS; MULTIVESICULAR BODIES;

EID: 84929506373     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2015.01.004     Document Type: Review

References (103)

1. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles 2013, 2:3-5.
2. Stein J.M., Luzio J.P. Exocytosis caused by sublytic autologous complement attack on human neutophils. The sorting of endogenous plasma membrane proteins and lipids into shed vesicles. Biochem. J. 1991, 274:381-386.
3. Cocucci E., Meldolesi J. Ectosomes. Curr. Biol. 2011, 21:R940-R941.
4. Harding C., et al. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 1983, 97:329-339.
5. Pan B.T., et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 1985, 101:942-948.
6. Johnstone R.M., et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 1987, 262:9412-9420.
7. Schifferli J.A. Microvesicles as messengers. Semin. Immunopathol. 2011, 33:393-394.
8. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 2010, 107:1047-1057.
9. Shifrin D.A., et al. Extracellular vesicles: communication, coercion, and conditioning. Mol. Biol. Cell 2013, 24:1253-1259.
10. Antonucci F., et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J. 2012, 31:1231-1240.
11. Fruhbeis C., et al. Extracellular vesicles as mediators of neuron-glia communication. Front. Cell. Neurosci. 2013, 7:182.
12. Turola E., et al. Microglial microvesicle secretion and intercellular signaling. Front. Physiol. 2012, 3:149.
13. Yoon Y.J., et al. Extracellular vesicles as emerging intercellular communications. BMB Rep. 2014, 47:531-539.
14. Choi D.S., et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013, 13:1554-1571.
15. Choi D.S., et al. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom. Rev. 2014, 95:26-30.
16. Haqqani A.S., et al. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluid Barriers CNS 2013, 10:4.
17. Bucci C., et al. Rab7: a key to lysosome biogenesis. Mol. Biol. Cell 2000, 11:467-480.
18. Luzio J.P., et al. The delivery of endocytosed cargo to lysosomes. Biochem. Soc. Trans. 2009, 38:1413-1416.
19. Luzio J.P., et al. Endosome-lysosome fusion. Biochem. Soc. Trans. 2010, 37:1019-1021.
20. Bissig C., Gruenberg J. ALIX and the multivesicular endosome. Alix in wonderland. Trends Cell Biol. 2014, 24:19-25.
21. Bobrie A., Thery C. Exosomes and communication between tumors and the immune system: are all exosomes equal?. Biochem. Soc. Trans. 2013, 41:263-267.
22. Kowal J., et al. Biogenesis and secretion of exosomes. Curr. Opin. Cell Biol. 2014, 29:116-125.
23. Chevallier J., et al. Lysobisphosphatic acid controls endosomal cholesterol levels. J. Biol. Chem. 2008, 283:27871-27880.
24. Morel O., et al. Cellular mchanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol. 2011, 31:15-26.
25. Kobayashi T., et al. Late endosomal membranes rich in ln lysobisphosphatic acid regulate cholesterol transport. Nat. Cell Biol. 1999, 1:113-118.
26. Kobayashi T., et al. Separation and characterization of late endosomal membrane domains. J. Biol. Chem. 2002, 277:32157-32164.
27. Trjkovic K., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
28. Buschov S.I., et al. Exosomes contain ubiquitinated proteins. Blood Cells Mol. Dis. 2005, 35:398-403.
29. Clague M.J., et al. Governance of endocytic traffiking and signaling by reversible ubiquitylation. Dev. Cell 2012, 23:457-467.
30. Henne W.M., et al. The ESCRT pathway. Dev. Cell 2011, 21:77-91.
31. Colombo M., et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 2013, 126:5553-5565.
32. Hurley J.H., Odorizzi G. Get on the exosome bus with ALIX. Nat. Cell Biol. 2012, 14:654-655.
33. Soldevilla B., et al. Tumor-derived exosomes are enriched in δNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival. Hum. Mol. Genet. 2014, 23:467-478.
34. van der Pol E., et al. Innovation in detection of microparticles and exosomes. J. Thromb. Haemost. 2013, 11(Suppl. 1):36-45.
35. Coleman B.M., et al. Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J. 2012, 26:4160-4173.
36. Cocucci E., et al. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009, 19:43-51.
37. Bianco F., et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009, 28:1043-1054.
38. Fang Y., et al. Higher order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 2007, 5:1267-1283.
39. Van Engelenburg S.B., et al. Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits. Science 2014, 343:653-656.
40. Nabhan J.F., et al. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:4146-4151.
41. Shen B., et al. Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 2011, 286:14383-14395.
42. Yang J.M., Gould S.J. The cis-acting signals that targets proteins to exosomes and microvesicles. Biochem. Soc. Trans. 2013, 41:277-2782.
43. Crescitelli R., et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J. Extracell. Vesicles 2013, Published online September 12, 2013. http://dx.doi.org/10.3402/jev.v2i0.20677.
44. Zhang W., et al. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS ONE 2013, 12:e67268.
45. Liao C.F., et al. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol. Med. 2012, 18:1269-1280.
46. Rilla K., et al. Hyaluronan production enhances shedding of plasma membrane-derived microvesicles. Exp. Cell Res. 2013, 319:2006-2018.
47. Lata S., et al. Helical structures of ESCRT-III are disassembled by Vps4. Science 2008, 321:1354-1357.
48. Saksena S., et al. Functional reconstitution of ESCRT-III assembly and disassembly. Cell 2009, 136:97-109.
49. Lenz M., et al. Membrane buckling induced by curved filaments. Phys. Rev. Lett. 2009, 103:038101.
50. Fabrikant G., et al. Computational model of membrane fission catalyzed by ESCRT-III. PLoS Comput. Biol. 2009, 5:e1000575.
51. Cashikar A.G., et al. Structure of cellular ESCRT-III spirals and their relationship to HIV budding. Elife 2014, 3:e02184.
52. Henne W.M., et al. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb. Perspect. Biol. 2013, 5:a016766.
53. Adeli M.A., et al. Coordinate binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J. Cell Biol. 2014, 205:33-49.
54. Shilagardi K., et al. Actin-propelled invasive membrane protrusions promote fusogenic protein engagement during cell-cell fusion. Science 2013, 340:359-363.
55. De Curtis I., Meldolesi J. Cell surface dynamics - how Rho GTPases orchestrate the interplay between the plasma membrane and the cortical cytoskeleton. J. Cell Sci. 2012, 125:4435-4444.
56. Muralidharan-Chari V., et al. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 2010, 123:1603-1611.
57. Antonyak M.A., et al. R(h)oads to microvesicles. Small GTPases 2012, 3:219-224.
58. Wiesner C., et al. A specific subset of Rab GTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J. Cell Sci. 2013, 126:2820-2833.
59. Bobrie A., et al. Exosome secretion: molecular mechanisms and role in immune responses. Traffic 2011, 12:1659-1668.
60. Hsu C., et al. Regulation of exosome secretion by Rab35 and its GTPase-activating protein TBC1D10A-C. J. Cell Biol. 2010, 189:223-232.
61. Ostrowski M., et al. Rab27a and Rab 27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010, 12:19-30.
62. Thery C., et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001, 166:7309-7318.
63. Ekstrom E.J., et al. Wnt5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol. Cancer 2014, 13:88.
64. Soo C.Y., et al. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 2012, 136:192-197.
65. 7) receptors in human dendritic cells induces the release of tissue factor-bearing particles. FASEB J. 2007, 21. 1926-1033.
66. Bianco F., et al. Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J. Immunol. 2005, 174:7268-7277.
67. Cocucci E., et al. Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both. Traffic 2007, 8:742-757.
68. Morris C.E., Homann U. Cell surface area regulation and membrane tension. J. Membr. Biol. 2001, 179:79-102.
69. 7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 2012, 14:1697-1706.
70. Proia P., et al. Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med. 2008, 21:63-67.
71. Lo Cicero A., et al. Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes. Int. J. Oncol. 2011, 39:1353-1357.
72. Owens A.P., Mackman N. Microparticles in homeostasis and thrombosis. Circ. Res. 2011, 108:1284-1297.
73. Kunder C.A., et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 2009, 206:112455-112467.
74. Lösche W., et al. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 2004, 15:109-115.
75. Sadallah S., et al. Microparticles (ectosomes) shed by stored human platelets down-regulate macrophages and modify the development of dendritic cells. J. Immunol. 2011, 186:6543-6552.
76. Eken C., et al. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology 2013, 218:382-392.
77. Steffen A., et al. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr. Biol. 2008, 18:926-931.
78. Aguilar P.S., et al. Genetic basis of cell-cell fusion mechanisms. Trends Genet. 2013, 29:427-437.
79. Perez-Vargas J., et al. Structural basis of eukaryotic cell-cell fusion. Cell 2014, 157:407-419.
80. Huang Q., et al. Epigenetic and non-epigenetic regulation of syncytin-1 expression in human placenta and cancer tissues. Cell. Signal. 2014, 26:648-656.
81. Bjerregard B., et al. Syncytin-1 in differentiating human myoblasts: relationship to caveolin-3 and myogenin. Cell Tissue Res. 2014, 357:355-362.
82. Tolosa J.M., et al. The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-stimulated cytokine responses in human blood and is sorted into placenta exosomes. Placenta 2012, 33:933-941.
83. Vargas A., et al. Syncytin proteins incorporated in placental exosome are important for cell uptake and show variations in abundance in serum exosomes from patients with pre-eclampsia. FASEB J. 2014, 28:3703-3719.
84. Tian T., et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J. Biol. Chem. 2014, 289:22258-22267.
85. Montecalvo A., et al. Mechanism of transfer and functional microRNAs between mouse dendritic cells via exosomes. Blood 2012, 119:756-766.
86. Li J., et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem. 2013, 288:23586-23596.
87. Skinner A.M., et al. Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells. PLoS ONE 2009, 4:e6219.
88. Hannafon B.N., Ding W.Q. Intercellular communication by exosome-derived miRNAs in cancer. Int. J. Mol. Sci. 2013, 14:14240-14269.
89. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200:373-383.
90. Atay S. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:711-716.
91. Sabin K., Kikyo N. Microvesicles as mediators of tissue regeneration. Transl. Res. 2014, 163:286-295.
92. Loyer X., et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ. Res. 2014, 114:345-353.
93. Raisi A., et al. The mesenchymal stem cell-derived microvesicles enhance sciatic nerve regeneration in rat: a novel approach in peripheral nerve cell therapy. J. Trauma Acute Care Surg. 2014, 76:991-997.
94. Ohno S., et al. Roles of exosomes and microvesicles in disease pathogenesis. Adv. Drug Deliv. Rev. 2013, 65:398-401.
95. Hulemans M., Holvoel P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res. 2013, 100:7-18.
96. D'Souza-Schorey C., Clancy J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and perspective cancer biomarkers. Genes Dev. 2012, 26:1287-1299.
97. He W.A., et al. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:4525-4529.
98. Katsuda T., et al. The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers. Proteomics 2014, 14:412-425.
99. Martins V.R., et al. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr. Opin. Oncol. 2013, 25:66-75.
100. Lasser C. Exosomes in the diagnostic and therapeutic applications: biomarkers, vaccine and RNA interference delivery vehicle. Expert. Opin. Biol. Ther. 2014, 1:1-15.
101. Fujita Y., et al. The impact of extracellular vesicle encapsulated circulating miRNAs in lung cancer research. Biomed. Res. Int. 2014, 2014:486413.
102. Van Dommelen S.M., et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 2012, 161:635-644.
103. Kanwar S.S., et al. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 2014, 14:1891-1900.